Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa
is indicated for bone metastasis
in most solid tumors. It carries a risk for osteonecrosis
of jaw. Usually it is stopped after 2 yrs if not earlier. Femara
is for post-menopausal BC who has positive ER/PR.